Trial
NCT03348904
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Incyte Corporation
Collaborators
Bristol-Myers Squibb
Condition
Lung Cancer
Intervention
Nivolumab
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-13